Profil Pasien Hipertensi di Rumah Sakit Jantung Hasna Medika Cirebon

  • Arbi Rizki Hidayat Universitas Swadaya Gunung Jati Cirebon
  • Yogi Puji Rachmawan Universitas Swadaya Gunung Jati Cirebon
  • Ade Yusuf Universitas Swadaya Gunung Jati Cirebon
Keywords: hipertensi, penyakit jantung koroner, penyakit kardiovaskular

Abstract

Hipertensi merupakan salah satu penyakit kardiovaskular yang paling banyak terjadi di dunia dan masih menjadi masalah kesehatan masyarakat karena berhubungan dengan peningkatan risiko penyakit jantung koroner, stroke, gagal jantung, dan penyakit ginjal. Peningkatan prevalensi hipertensi, khususnya di negara berkembang, menunjukkan pentingnya pemahaman mengenai karakteristik pasien untuk meningkatkan efektivitas pengelolaan penyakit. Penelitian ini bertujuan untuk mengetahui profil pasien hipertensi di Rumah Sakit Jantung Hasna Medika Cirebon. Penelitian menggunakan desain kuantitatif deskriptif analitik dengan pendekatan cross sectional. Populasi penelitian adalah pasien hipertensi rawat jalan periode Januari–Maret 2023 dengan teknik total sampling sehingga diperoleh 906 data pasien. Data dikumpulkan melalui rekam medis dan dianalisis menggunakan analisis univariat dengan bantuan perangkat lunak SPSS. Hasil penelitian menunjukkan bahwa mayoritas pasien mengalami hipertensi derajat 1 (58,3%), berjenis kelamin perempuan (72,1%), dan berada pada kelompok lanjut usia ≥60 tahun (47,8%). Jenis obat antihipertensi yang paling banyak digunakan adalah beta bloker kardioselektif (75,2%) dengan terapi kombinasi dua obat sebagai regimen terbanyak (32,8%). Penyakit jantung koroner menjadi komorbiditas yang paling sering ditemukan (54,7%). Kesimpulan penelitian menunjukkan bahwa pasien hipertensi di Rumah Sakit Jantung Hasna Medika Cirebon didominasi perempuan lanjut usia dengan hipertensi derajat 1 dan komorbiditas kardiovaskular sehingga memerlukan penatalaksanaan hipertensi yang komprehensif dan berkelanjutan.

Downloads

Download data is not yet available.

References

Abatur, S. C., Anyaji, U. L., Injor, I. R., & Onuh, D. F. (2023). Prevalence and risk factors of hypertension among HIV patients: A retrospective cross sectional study of a Nigerian tertiary hospital. International Journal of Science and Research Archive, 9(1), 318–327. https://doi.org/10.30574/ijsra.2023.9.1.0399

Abdisa, L., Letta, S., & Nigussie, K. (2022). Depression and anxiety among people with hypertension on follow-up in eastern Ethiopia: A multi-center cross-sectional study. Frontiers in Psychiatry, 13, 1–10. https://doi.org/10.3389/fpsyt.2022.853551

Abdullah, D., Dewi, N. P., Monaprlya, D., & Chan, Z. (2024). Profil Penderita Hipertensi di RSUD Pasaman Barat tahun 2022. Nusantara Hasana Journal, 3(11), 1–13. https://nusantarahasanajournal.com/index.php/nhj/article/view/1112

Adua, E. (2022). Decoding the mechanism of hypertension through multiomics profiling. Journal of Human Hypertension, 37(4), 253–264. https://doi.org/10.1038/s41371-022-00769-8

Al-Ahmari, A. K. (2022). Prevalence of hypertension and its associated risk factors among patients with rheumatoid arthritis in the Kingdom of Saudi Arabia. International Journal of General Medicine, 15, 6507–6517. https://doi.org/10.2147/ijgm.s370956

Andria, K. M., Widati, S., & Nurmala, I. (2021). The characteristics of hypertension patients at Puskesmas Waru, Pamekasan in 2018. Jurnal PROMKES, 9(1), 11. https://doi.org/10.20473/jpk.v9.i1.2021.11-17

Association, A. H. (2023). Know your risk factors for high blood pressure. https://www.heart.org/en/health-topics/high-blood-pressure/why-high-blood-pressure-is-a-silent-killer/know-your-risk-factors-for-high-blood-pressure

Bawazier, L. A. (2019). Profile of Hypertensive Patients in Indonesia National Referral Hospital. EJournal Kedokteran Indonesia, 7(2). https://doi.org/10.23886/ejki.7.10867

Bulqiah, A., Suprapti, B., Ardiana, S. M., Alsagaff, M. Y., & Suharjono. (2023). Use of medication in outpatient hypertension patients. Window of Health, 6(2), 119–130. https://jurnal.fkmumi.ac.id/index.php/woh/article/view/66

Christian, A. K., Sanuade, O. A., Kushitor, S. B., Kushitor, M., Kretchy, I., Agyemang, C., & de-Graft Aikins, A. (2021). Metabolic syndrome among individuals living with hypertension in Accra, Ghana. PLOS ONE, 16(10), 2–14. https://doi.org/10.1371/journal.pone.0253837

Churchhouse, C., & Ormerod, O. (2017). Crash Course: Kardiologi dan Kelainan Vaskular (1st ed.). Elsevier.

Cirebon, D. K. I. dan S. K. (2020). 10 Kasus Penyakit Terbanyak di Kota Cirebon. https://data.cirebonkota.go.id/dataset/b6762f4d-9aaf-5be3-b34f-066b269047c0/dokumen/bac601c1-3ffe-5589-ada7-c226508a85f0

Cirebon, D. K. K. (2021a). Profil Kesehatan Kabupaten Cirebon Tahun 2020.

Cirebon, D. K. K. (2021b). Profil Kesehatan Kota Cirebon Tahun 2021.

Eberhardt, R. T., & Raffetto, J. D. (2014). Chronic venous insufficiency. Circulation, 130(4), 333–346. https://doi.org/10.1161/CIRCULATIONAHA.113.006898

Ferdinand, K. C., Sadik, K., Browne, R., Desai, U., Lefebvre, P., Lejeune, D., Sheng, D., & Picard-Ami, L. (2023). Real-world racial variation in treatment and outcomes among patients with peripheral artery disease. Advances in Therapy, 40(4), 1850–1866. https://doi.org/10.1007/s12325-023-02465-6

George, N. G., & Pilly, C. (2021). Prevalence, types and clinical presentation of heart failure among hypertensive patients seen at a tertiary hospital in Dar es Salaam, Tanzania. International Journal of Clinical Cardiology, 8(3), 1–8. https://doi.org/10.23937/2378-2951/1410230

Goud, P., & Ashik, C. (2023). Assessment of comorbidities, polypharmacy and drug therapy problems among hypertensive patients at a tertiary care teaching hospital. International Journal for Multidisciplinary Research, 5(3), 1–10. https://doi.org/10.36948/ijfmr.2023.v05i03.3117

Hegde, S., Ahmed, I., & Aeddula, N. R. (2023). Secondary Hypertension. U.S. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK544305/

Herliany, Y. S., & Wahyuningsih, S. R. (2020). The profile of antihypertensive drug prescriptions and interactions at Pindad General Hospital. Pharmacology and Clinical Pharmacy Research, 5(1), 1. https://doi.org/10.15416/pcpr.v5i1.26172

Hinton, T. C., Adams, Z. H., Baker, R. P., Hope, K. A., Paton, J. F. R., Hart, E. C., & Nightingale, A. K. (2019). Investigation and treatment of high blood pressure in young people. Hypertension, 75(1), 16–22. https://doi.org/10.1161/HYPERTENSIONAHA.119.13820

Iqbal, A. M., & Jamal, S. F. (2023). Essential Hypertension. U.S. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK539859/#article-21370.s3

Jia, G., & Sowers, J. R. (2021). Hypertension in diabetes: An update of basic mechanisms and clinical disease. Hypertension, 78(5), 1197–1205. https://doi.org/10.1161/HYPERTENSIONAHA.121.17510

Khalil, R., Nasim, S., & Kumar, N. (2022). Gender difference in lipid profile in hypertensive patients’ hospital-based study. Cardiology: Open Access, 7(1), 195–199. https://doi.org/10.33140/coa.07.01.05

Lukito, A. A., Harmeiwaty, E., & Hustrini, N. M. (2019). Konsensus Penatalaksanaan Hipertensi 2019. Perhimpunan Dokter Hipertensi Indonesia.

Ma, J., & Chen, X. (2022). Advances in pathogenesis and treatment of essential hypertension. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.1003852

Medscape. (2023a). amlodipine (Rx). https://reference.medscape.com/drug/katerzia-norvasc-amlodipine-342372#10

Medscape. (2023b). bisoprolol (Rx). https://reference.medscape.com/drug/monocor-zebeta-bisoprolol-342367#10

Medscape. (2023c). candesartan (Rx). https://reference.medscape.com/drug/atacand-candesartan-342314#10

Medscape. (2023d). captopril (Rx). https://reference.medscape.com/drug/capoten-captoril-captopril-342315

Medscape. (2023e). carvedilol (Rx). https://reference.medscape.com/drug/coreg-cr-carvedilol-342357#10

Medscape. (2023f). clonidine (Rx). https://reference.medscape.com/drug/catapres-tts-onyda-xr-clonidine-342382#10

Medscape. (2023g). furosemide (Rx). https://reference.medscape.com/drug/lasix-furoscix-furosemide-342423#10

Medscape. (2023h). hydrochlorothiazide (Rx). https://reference.medscape.com/drug/microzide-hydrodiuril-hydrochlorothiazide-342412#10

Medscape. (2023i). nebivolol (Rx). https://reference.medscape.com/drug/bystolic-nebivolol-342363#10

Medscape. (2023j). propranolol (Rx). https://reference.medscape.com/drug/inderal-inderal-la-propranolol-342364#10

Medscape. (2023k). spironolactone (Rx). https://reference.medscape.com/drug/carospir-aldactone-spironolactone-342407#10

Medscape. (2023l). verapamil (Rx). https://reference.medscape.com/drug/calan-sr-isoptin-sr-verapamil-342380#10

Organization, W. H. (2023). Hypertension. https://www.who.int/news-room/fact-sheets/detail/hypertension

Oyan, B., & Abere, S. T. (2022). Prevalence and risk factors for peripheral arterial disease in adults with systemic hypertension in southern Nigeria. GSC Advanced Research and Reviews, 10(3), 98–103. https://doi.org/10.30574/gscarr.2022.10.3.0082

Rahayu, P. S., & Usviany, V. (2023). Pola penggunaan obat antihipertensi pasien rawat jalan di RSAU dr. M. Salamun periode Juni 2023. Health Information: Jurnal Penelitian, 15(2), e1129. https://myjurnal.poltekkes-kdi.ac.id/index.php/hijp/article/view/1129

RI, K. (2019). Laporan Nasional Riskesdas 2018.

RI, K. K. (2016). Peraturan Menteri Kesehatan Nomor 25 Tahun 2016 tentang Rencana Aksi Nasional Kesehatan Lanjut Usia Tahun 2016-2019. Kementerian Kesehatan RI.

RI, K. K. (2019). Hipertensi Penyakit Paling Banyak Diidap Masyarakat. https://sehatnegeriku.kemkes.go.id/baca/umum/20190517/5130282/hipertensihiperten-paling-banyak-diidap-masyarakat/

Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., Gersh, B. J., Gore, J. M., Levy, D., Long, J. B., O’Connor, C. M., O’Gara, P. T., Ogedegbe, G., Oparil, S., & White, W. B. (2015). Treatment of hypertension in patients with coronary artery disease. Circulation, 131(19), e435–e470. https://doi.org/10.1161/CIR.0000000000000207

Shin, D., Choi, J., & Lee, H. Y. (2023). Suboptimal control status of young hypertensive population. Clinical Hypertension, 29(1), 1–9. https://doi.org/10.1186/s40885-023-00237-6

Silva, E., Borges, J., Moreira, T., Rodrigues, M., & Souza, A. (2020). Prevalence and risk factors associated with stroke in hypertensive patients: a hierarchical analysis. Revista de Enfermagem Referência, 5(3), 1–8. https://doi.org/10.12707/rv20014

Sulistiawati, S., Dewanti, L., Pratama, A. P., Atika, A., Fatmaningrum, W., Nuswantoro, D., Octora, T. N., Pradnyaparamitha, D. A., & Rizqi, F. A. (2020). Profile and lifestyle of hypertensive patients, cardiovascular comorbidity, and complications in a primary health center in Surabaya, Indonesia. Open Access Macedonian Journal of Medical Sciences, 8(E), 219–223. https://oamjms.eu/index.php/mjms/article/view/4432

Sun, K., Lin, D., Li, M., Mu, Y., Zhao, J., Liu, C., Shi, X., Tian, H., Yang, T., Yan, L., Wan, Q., Wu, S., Liu, Y., Wang, G., Luo, Z., Tang, X., Chen, L., Huo, Y., & Ning, G. (2021). Association of education levels with the risk of hypertension and hypertension control: a nationwide cohort study in Chinese adults. Journal of Epidemiology and Community Health, 76(5), 451–457. https://doi.org/10.1136/jech-2021-217006

Tanto, C., & Hustrini, N. M. (2014). Hipertensi. In C. Tanto, F. Liwang, S. Hanifati, & E. A. Pradipta (Eds.), Kapita Selekta Kedokteran (4th ed., Vol. 2, pp. 636–639). Media Aesculapius.

Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A. J., Schlaich, M., Stergiou, G. S., Tomaszewski, M., Wainford, R. D., Williams, B., & Schutte, A. E. (2020). 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 75(6), 1334–1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026

Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., Kahan, T., Mahfoud, F., Redon, J., Ruilope, L., Zanchetti, A., Kerins, M., Kjeldsen, S. E., Kreutz, R., Laurent, S., … Desormais, I. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal, 39(33), 3021–3104. https://doi.org/10.1093/eurheartj/ehy339

Yuniati, N. I. (2022). Profil Pasien Hipertensi di Puskesmas Purwokerto Utara. Jurnal BCH, 18(1), 140–145. https://jurnal.stikesbch.ac.id/index.php/jurnal/article/view/63

Published
2026-05-25